Other factors shown to be involved in the improvement in anaemia following SGLT‐2 inhibition include reduced hepcidin and ferritin leading to increased iron absorption and mobilization and increased hypoxia‐inducible factor 2α.28 This evidence concerns the gene SLC5A2 and anemia.